NLRP1炎性小体的激活机制

doi:10.11843/j.issn.0366-6964.2023.02.008

Abstract

Abstract: Nucleotide-binding oligomerization domain-like receptor protein 1 (NLRP1) is a member of the NOD-like receptors (NLRs) family, and is the first NLR family protein found to form inflammasome. The activation of NLRP1 can cause the activation of pro-caspase-1 and further promote the maturation and release of inflammatory factors, which plays an important role in innate immunity. The domain structure of NLRP1 varies among different species. At present, the mechanisms that can cause NLRP1 activation mainly include degradation and activation of NLRP1 through proteasome pathway, activation of NLRP1 through inhibition of DPP9, and activation of NLRP1 by Toxoplasma gondii and some metabolic inhibitors. Some viral proteins or RNAs can also activate NLRP1. How the virus activates NLRP1 and the role of NLRP1 in antiviral infection are not clear, and need to be further studied.

Key words: NLRP1, inflammasome, virus, activation mechanism

CLC Number:

S852.4

HE Haojie, XUE Mei, FENG Li. Activation Mechanism of NLRP1 Inflammasome[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(2): 494-503.

References 79

[1]	THAISS C A, ZMORA N, LEVY M, et al. The microbiome and innate immunity[J]. Nature, 2016, 535(7610):65-74.
[2]	DEMARIA O, CORNEN S, DAËRON M, et al. Harnessing innate immunity in cancer therapy[J]. Nature, 2019, 574(7776):45-56.
[3]	LI D Y, WU M H. Pattern recognition receptors in health and diseases[J]. Sig Transduct Target Ther, 2021, 6(1):291.
[4]	KANNEGANTI T D. Intracellular innate immune receptors:life inside the cell[J]. Immunol Rev, 2020, 297(1):5-12.
[5]	DIAMOND M S, KANNEGANTI T D. Innate immunity:the first line of defense against SARS-CoV-2[J]. Nat Immunol, 2022, 23(2):165-176.
[6]	FITZGERALD K A, KAGAN J C. Toll-like receptors and the control of immunity[J]. Cell, 2020, 180(6):1044-1066.
[7]	BROZ P, DIXIT V M. Inflammasomes:mechanism of assembly, regulation and signalling[J]. Nat Rev Immunol, 2016, 16(7):407-420.
[8]	SHI J J, ZHAO Y, WANG K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526(7575):660-665.
[9]	KAYAGAKI N, STOWE I B, LEE B L, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J]. Nature, 2015, 526(7575):666-671.
[10]	BURDETTE B E, ESPARZA A N, ZHU H, et al. Gasdermin D in pyroptosis[J]. Acta Pharm Sin B, 2021, 11(9):2768-2782.
[11]	MARTINON F, BURNS K, TSCHOPP J. The inflammasome:a molecular platform triggering activation of inflammatory caspases and processing of proIL-β[J]. Mol Cell, 2002, 10(2):417-426.
[12]	SHAW M H, REIMER T, KIM Y G, et al. NOD-like receptors (NLRs):bona fide intracellular microbial sensors[J]. Curr Opin Immunol, 2008, 20(4):377-382.
[13]	TING J P Y, LOVERING R C, ALNEMRI E S, et al. The NLR gene family:a standard nomenclature[J]. Immunity, 2008, 28(3):285-287.
[14]	LUPFER C, KANNEGANTI T D. The expanding role of NLRs in antiviral immunity[J]. Immunol Rev, 2013, 255(1):13-24.
[15]	DANIS J, MELLETT M. Nod-like receptors in host defence and disease at the epidermal barrier[J]. Int J Mol Sci, 2021, 22(9):4677.
[16]	QIAN X K, ZHANG J, LI X D, et al. Research progress on dipeptidyl peptidase family:structure, function and xenobiotic metabolism[J]. Curr Med Chem, 2022, 29(12):2167-2188.
[17]	BENTHAM A, BURDETT H, ANDERSON P A, et al. Animal NLRs provide structural insights into plant NLR function[J]. Ann Bot, 2017, 119(5):698-702.
[18]	HU Z H, YAN C Y, LIU P Y, et al. Crystal structure of NLRC4 reveals its autoinhibition mechanism[J]. Science, 2013, 341(6142):172-175.
[19]	MOTTA V, SOARES F, SUN T, et al. NOD-like receptors:versatile cytosolic sentinels[J]. Physiol Rev, 2015, 95(1):149-178.
[20]	LIU P, LU Z W, LIU L L, et al. NOD-like receptor signaling in inflammation-associated cancers:from functions to targeted therapies[J]. Phytomedicine, 2019, 64:152925.
[21]	MASTERNAK K, MUHLETHALER-MOTTET A, VILLARD J, et al. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex[J]. Genes Dev, 2000, 14(9):1156-1166.
[22]	MAIER J K X, LAHOUA Z, GENDRON N H, et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7[J]. J Neurosci, 2002, 22(6):2035-2043.
[23]	DAVOODI J, GHAHREMANI M H, ES-HAGHI A, et al. Neuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9[J]. Int J Biochem Cell Biol, 2010, 42(6):958-964.
[24]	SANNA M G, DA SILVA CORREIA J, DUCREY O, et al. IAP suppression of apoptosis involves distinct mechanisms:the TAK1/JNK1 signaling cascade and caspase inhibition[J]. Mol Cell Biol, 2002, 22(6):1754-1766.
[25]	HAUSMANN A, BÖCK D, GEISER P, et al. Intestinal epithelial NAIP/NLRC4 restricts systemic dissemination of the adapted pathogen Salmonella typhimurium due to site-specific bacterial PAMP expression[J]. Mucosal Immunol, 2020, 13(3):530-544.
[26]	CORREA R G, MILUTINOVIC S, REED J C. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases[J]. Biosci Rep, 2012, 32(6):597-608.
[27]	VELLOSO F J, TROMBETTA-LIMA M, ANSCHAU V, et al. NOD-like receptors:major players (and targets) in the interface between innate immunity and cancer[J]. Biosci Rep, 2019, 39(4):BSR20181709.
[28]	SCHRODER K, TSCHOPP J. The inflammasomes[J]. Cell, 2010, 140(6):821-832.
[29]	TATTOLI I, CARNEIRO L A, JéHANNO M, et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production[J]. EMBO Rep, 2008, 9(3):293-300.
[30]	STOKMAN G, KORS L, BAKKER P J, et al. NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity[J]. J Exp Med, 2017, 214(8):2405-2420.
[31]	TSCHOPP J, MARTINON F, BURNS K. NALPs:a novel protein family involved in inflammation[J]. Nat Rev Mol Cell Biol, 2003, 4(2):95-104.
[32]	YU C H, MOECKING J, GEYER M, et al. Mechanisms of NLRP1-mediated autoinflammatory disease in humans and mice[J]. J Mol Biol, 2018, 430(2):142-152.
[33]	ZHONG F L, MAMAÏ O, SBORGI L, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation[J]. Cell, 2016, 167(1):187-202. e17.
[34]	CHAVARRÍA-SMITH J, MITCHELL P S, HO A M, et al. Functional and evolutionary analyses identify proteolysis as a general mechanism for NLRP1 inflammasome activation[J]. PLoS Pathog, 2016, 12(12):e1006052.
[35]	FINGER J N, LICH J D, DARE L C, et al. Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity[J]. J Biol Chem, 2012, 287(30):25030-25037.
[36]	XUE Y S, ENOSI TUIPULOTU D, TAN W H, et al. Emerging activators and regulators of inflammasomes and pyroptosis[J]. Trends Immunol, 2019, 40(11):1035-1052.
[37]	D'OSUALDO A, WEICHENBERGER C X, WAGNER R N, et al. CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain[J]. PLoS One, 2011, 6(11):e27396.
[38]	FAUSTIN B, LARTIGUE L, BRUEY J M, et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation[J]. Mol Cell, 2007, 25(5):713-724.
[39]	LILUE J, DORAN A G, FIDDES I T, et al. Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci[J]. Nat Genet, 2018, 50(11):1574-1583.
[40]	CHAVARRÍA-SMITH J, VANCE R E. Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor[J]. PLoS Pathog, 2013, 9(6):e1003452.
[41]	ROBERTS J E, WATTERS J W, BALLARD J D, et al. Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11[J]. Mol Microbiol, 1998, 29(2):581-591.
[42]	WICKLIFFE K E, LEPPLA S H, MOAYERI M. Killing of macrophages by anthrax lethal toxin:involvement of the N-end rule pathway[J]. Cell Microbiol, 2008, 10(6):1352-1362.
[43]	BOYDEN E D, DIETRICH W F. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin[J]. Nat Genet, 2006, 38(2):240-244.
[44]	LEVINSOHN J L, NEWMAN Z L, HELLMICH K A, et al. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome[J]. PLoS Pathog, 2012, 8(3):e1002638.
[45]	CHUI A J, OKONDO M C, RAO S D, et al. N-terminal degradation activates the NLRP1B inflammasome[J]. Science, 2019, 364(6435):82-85.
[46]	SANDSTROM A, MITCHELL P S, GOERS L, et al. Functional degradation:a mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes[J]. Science, 2019, 364(6435):eaau1330.
[47]	TAABAZUING C Y, GRISWOLD A R, BACHOVCHIN D A. The NLRP1 and CARD8 inflammasomes[J]. Immunol Rev, 2020, 297(1):13-25.
[48]	MITCHELL P S, SANDSTROM A, VANCE R E. The NLRP1 inflammasome:new mechanistic insights and unresolved mysteries[J]. Curr Opin Immunol, 2019, 60:37-45.
[49]	WILSON C H, ZHANG H E, GORRELL M D, et al. Dipeptidyl peptidase 9 substrates and their discovery:current progress and the application of mass spectrometry-based approaches[J]. Biol Chem, 2016, 397(9):837-856.
[50]	OKONDO M C, JOHNSON D C, SRIDHARAN R, et al. DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis[J]. Nat Chem Biol, 2017, 13(1):46-53.
[51]	OKONDO M C, RAO S D, TAABAZUING C Y, et al. Inhibition of Dpp8/9 activates the Nlrp1b inflammasome[J]. Cell Chem Biol, 2018, 25(3):262-267. e5.
[52]	ZHONG F L, ROBINSON K, TEO D E T, et al. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding[J]. J Biol Chem, 2018, 293(49):18864-18878.
[53]	GRISWOLD A R, CIFANI P, RAO S D, et al. A chemical strategy for protease substrate profiling[J]. Cell Chem Biol, 2019, 26(6):901-907. e6.
[54]	JOHNSON D C, TAABAZUING C Y, OKONDO M C, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia[J]. Nat Med, 2018, 24(8):1151-1156.
[55]	HUANG M H, ZHANG X X, TOH G A, et al. Structural and biochemical mechanisms of NLRP1 inhibition by DPP9[J]. Nature, 2021, 592(7856):773-777.
[56]	HOLLINGSWORTH L R, SHARIF H, GRISWOLD A R, et al. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation[J]. Nature, 2021, 592(7856):778-783.
[57]	CIRELLI K M, GORFU G, HASSAN M A, et al. Inflammasome sensor NLRP1 controls rat macrophage susceptibility to Toxoplasma gondii[J]. PLoS Pathog, 2014, 10(3):e1003927.
[58]	EWALD S E, CHAVARRIA-SMITH J, BOOTHROYD J C. NLRP1 is an inflammasome sensor for Toxoplasma gondii[J]. Infect Immun, 2014, 82(1):460-468.
[59]	WITOLA W H, MUI E, HARGRAVE A, et al. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells[J]. Infect Immun, 2011, 79(2):756-766.
[60]	GORFU G, CIRELLI K M, MELO M B, et al. Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii[J]. mBio, 2014, 5(1):e01117-13.
[61]	ZHU L J, QI W J, YANG G, et al. Toxoplasma gondii rhoptry protein 7 (ROP7) interacts with NLRP3 and promotes inflammasome hyperactivation in THP-1-derived macrophages[J]. Cells, 2022, 11(10):1630.
[62]	DUNCAN J A, BERGSTRALH D T, WANG Y H, et al. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling[J]. Proc Natl Acad Sci U S A, 2007, 104(19):8041-8046.
[63]	LIAO K C, MOGRIDGE J. Activation of the Nlrp1b inflammasome by reduction of cytosolic ATP[J]. Infect Immun, 2013, 81(2):570-579.
[64]	ROBINSON K S, TEO D E T, TAN K S, et al. Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia[J]. Science, 2020, 370(6521):eaay2002.
[65]	TSU B V, BEIERSCHMITT C, RYAN A P, et al. Diverse viral proteases activate the NLRP1 inflammasome[J]. Elife, 2021, 10:e60609.
[66]	NOZAKI K, LI L P, MIAO E A. Innate sensors trigger regulated cell death to combat intracellular infection[J]. Ann Rev Immunol, 2022, 40:469-498.
[67]	PLANōS R, PINILLA M, SANTONI K, et al. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells[J]. Mol Cell, 82(13):2385-2400.
[68]	WANG Q K, GAO H B, CLARK K M, et al. CARD8 is an inflammasome sensor for HIV-1 protease activity[J]. Science, 2021, 371(6535):eabe1707.
[69]	HOLLINGSWORTH L R, DAVID L, LI Y, et al. Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes[J]. Nat Commun, 2021, 12(1):189.
[70]	YANG X, ZHOU J F, LIU C R, et al. KSHV-encoded ORF45 activates human NLRP1 inflammasome[J]. Nat Immunol, 2022, 23(6):916-926.
[71]	BAUERNFRIED S, SCHERR M J, PICHLMAIR A, et al. Human NLRP1 is a sensor for double-stranded RNA[J]. Science, 2021, 371(6528):eabd0811.
[72]	TUPIK J D, NAGAI-SINGER M A, ALLEN I C. To protect or adversely affect?The dichotomous role of the NLRP1 inflammasome in human disease[J]. Mol Aspects Med, 2020, 76:100858.
[73]	ALEHASHEMI S, GOLDBACH-MANSKY R. Human autoinflammatory diseases mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-inflammasome dysregulation updates on diagnosis, treatment, and the respective roles of IL-1 and IL-18[J]. Front Immunol, 2020, 11:1840.
[74]	SAND J, FENINI G, GROSSI S, et al. The NLRP1 inflammasome pathway is silenced in cutaneous squamous cell carcinoma[J]. J Invest Dermatol, 2019, 139(8):1788-1797. e6.
[75]	FENINI G, KARAKAYA T, HENNIG P, et al. The NLRP1 inflammasome in human skin and beyond[J]. Int J Mol Sci, 2020, 21(13):4788.
[76]	YAP J K Y, PICKARD B S, CHAN E W L, et al. The role of neuronal NLRP1 inflammasome in Alzheimer's disease:bringing neurons into the neuroinflammation game[J]. Mol Neurobiol, 2019, 56(11):7741-7753.
[77]	MULLARD A. NLRP3 inhibitors stoke anti-inflammatory ambitions[J]. Nat Rev Drug Discov, 2019, 18(6):405-407.
[78]	DE BRITO TOSCANO E C, ROCHA N P, LOPES B N A, et al. Neuroinflammation in Alzheimer's disease:focus on NLRP1 and NLRP3 inflammasomes[J]. Curr Protein Pept Sci, 2021, 22(8):584-598.
[79]	WANG P H, ZHU S, YANG L, et al. Nlrp6 regulates intestinal antiviral innate immunity[J]. Science, 2015, 350(6262):826-830.

Activation Mechanism of NLRP1 Inflammasome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 79

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	CHEN Songbiao, LIU Feifei, SHANG Ke, YU Zuhua, HE Lei, WEI Ying, CHEN Jian, ZHANG Chunjie, CHENG Xiangchao, DING Ke. Molecular Mechanism of the “Battle” between Virus Infection and Host Antiviral Immunity-Apoptosis, Necroptosis and Pyroptosis [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 59-70.
[2]	CHEN Shuyu, ZHU Xuejiao, ZHOU Jinzhu, TAO Ran, ZHANG Xuehan, Suolangsizhu, Gongga, LI Bin. Inhibition of Porcine Rotavirus in vitro Replication by Guanylate-binding Proteins GBP1 and GBP2 [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 245-257.
[3]	SONG Wenyan, ZHANG Hanwen, WU Aodi, ZHANG Liyan, LIU Zhao, YE Tongtong, CHEN Chuangfu, SHENG Jinliang. Screening of Nanobodies against Porcine Reproductive and Respiratory Syndrome Virus GP5 Protein and Exploration of Their Inhibitory Effect on Virus Replication [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 258-270.
[4]	LIU Chuanxia, WANG Xiao, LI Xuewen, BAO Miaofei, LI Tingting, CHEN Xin, WENG Changjiang, ZHENG Jun. Preparation of Monoclonal Antibody of African Swine Fever Virus pE120R [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 388-394.
[5]	YANG Heng, LI Zhanhong, SONG Zi'ang, GAO Lin, LI Zhuoran, LIAO Defang, XIAO Lei, LI Huachun. Development and Application of Serotyping Real-time Quantitative RT-PCR Methods for Palyam Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 395-400.
[6]	WANG Ying, LI Jiakang, ZENG Yue, SHI Kaituo, WEI Liting, PENG Jiajia, LI Qiuyan, CAO Longlong, ZHOU Dengyuan. Development of Monoclonal Antibodies against Feline Calicivirus [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 401-405.
[7]	LI Huihui, DONG Keer, LIU Xinbo, ZHANG Chunxiao, MA Chao, CHEN Liping, ZHONG Qi, YAO Gang, MA Xuelian. Establishment and Application of Rapid Detection Method for Bovine Norovirus and Bovine Rotavirus Dual RAA-LFD [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 406-412.
[8]	ZHOU Jianhao, WANG Dongfang, LIU Ying, WANG Shujuan, MA Zhenyuan, XIE Caihua, ZHAO Xueli, YANG Haibo, FENG Guidan, KANG Taisheng, HU Yufeng, LI Bowen, YAN Ruoqian. Establishment and Preliminary Application of a Quantitative Droplet Digital PCR Assay for Porcine Epidemic Diarrhea Virus [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(1): 413-418.
[9]	YANG Zhiyi, WANG Xinkai, SHI Yuting, FU Siyuan, ZHANG Yuxin, CAO Chenfu, JIA Weixin. Establishment of Nucleic Acid Detection Methods for Avian Influenza H5 Subtype Based on CRISPR-Cas13a and RT-RAA [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3803-3811.
[10]	WANG Zhiyuan, LIU Boqi, XU Zhiying, XU Sijia, XING Jiabao, ZHANG Guihong, WANG Heng, SUN Yankuo. Analysis of ORF5 Gene Variation of Porcine Reproductive and Respiratory Syndrome Virus in Local Regions of China from 2021 to 2022 [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3812-3823.
[11]	FAN Yandi, YANG Danjiao, YE Zhongming, ZHANG Min, LAN Lan, WANG Jinghao, ZHOU Han, KANG Runmin, YU Jifeng, ZHANG Zhidong, LI Yanmin, ZHOU Long. Metagenomic Analysis of Viruses in Clinical Samples of Respiratory Diseases in Tibetan Pigs [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3836-3847.
[12]	ZHAO Yongpan, ZHENG Fangfang, YIN Junqing, DU Qian, TONG Dewen, HUANG Yong. Establishment and Application of Magnetic Nanoparticle Visualization Technique for Nucleic Acid Detection of Seven Common Swine Viruses [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3848-3862.
[13]	JIANG Lingling, NIU Xiaoxia, LIU Qiang, ZHANG Gang, WANG Pu, LI Yong. Analysis of Infection Status of Beef Cattle Diarrhea-related Virus in Ningxia [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3863-3871.
[14]	LIU Hua, YIN Dongdong, SHAO Ying, SONG Xiangjun, WANG Zhenyu, PAN Xiaocheng, TU Jian, HE Changsheng, ZHU Liangqiang, QI Kezong. Detection of Porcine Epidemic Diarrhea Virus by Recombinase Aided Amplification Combined with CRISPR/Cas13a [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(9): 3991-3997.
[15]	WANG Ziyue, ZHANG Zihui, WU Wenxue, PENG Chen. Monkeypox: Diagnosis, Prevention and Treatments [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(8): 3195-3205.